Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Transplant Surgery
  •  Minimally Invasive Surgery
  •  Emergency Surgery
  •  Breast Surgery
  •  Neurological Surgery
  •  Gastroenterological Surgery
  •  Urology
  •  Otolaryngology - Head and Neck Surgery

Abstract

Citation: Clin Surg. 2022;7(1):3473.Case Report | Open Access

EML4-ALK (E13:A20) and GPAT3-ALK (G3:A20) Mutations from a Patient with Lung Adenocarcinoma

Tian Tan1, Junfeng Wan3, Hong Wu1, Chenhui Cao1, Yang Liu3, Gang Li2* and Chuan Xu1*

1Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, China
2Department of Thoracic Surgery, Sichuan Provincial People's Hospital, Medicine University of Electronic Science and Technology of China, China
3Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, China

*Correspondance to: Chuan Xu 

 PDF  Full Text DOI: 10.25107/2474-1647.3473

Abstract

Background: Anaplastic Lymphoma Kinase (ALK) gene rearrangements appear in 5% to 7% lung adenocarcinoma. With the development of Next-Generation Sequencing (NGS), increasing ALK gene variation (rearrangement/fusion, mutation or amplification) has been discovered. The result of NGS, which could predict the sensitivity of TKI drugs, shows a good correlation with tumor development and therapeutic effect. Case Report: Herein, we report the case of a 49-year-old man who was diagnosed with lung adenocarcinoma and was undergoing ensartinib treatment. The analysis of NGS detected a new ALK fusion combination, namely EML4-ALK and GPAT3-ALK. According to the result of NGS, this patient has higher sensitivity to some TKI drugs. Discussion: Different types of ALK gene mutations are common in lung adenocarcinoma and different degrees of influence on tumors. This case report demonstrates the effectiveness of using NGS to discover novel ALK fusion genes and guide individual therapy.

Keywords

Cite the article

Tan T, Wan J, Wu H, Cao C, Liu Y, Li G, et al. EML4-ALK (E13:A20) and GPAT3- ALK (G3:A20) Mutations from a Patient with Lung Adenocarcinoma. Clin Surg. 2022; 7: 3473..

Search Our Journal

Journal Indexed In

Articles in PubMed

Risk Factors for Visual Impairment in an Uninsured Population and the Impact of the Affordable Care Act
 PubMed  PMC  PDF  Full Text
Mesh Sprayer Device with Liquefied Mesh Delivery System: Proposed Alternative for Currently Available Meshes in Hernia Repair and Supplement to Abdominal Closure
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

A Model of Cecal Ligation and Puncture Mimicking Perforated Diverticulitis with Purulent Peritonitis
 Abstract  PDF  Full Text
Prediction of Cardiovascular Diseases from Risk Factor: An Application of Machine Learning
 Abstract  PDF  Full Text
View More...